RHYTHM PHARMACEUTICALS, INC. (RYTM) has 84 open-market insider trades by 27 insiders since 2017. Over the last six months insiders net sold $428K. The most active filer is Todd Foley, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Todd Foley | Dir | — | 21 | $65.0M | 2021-03-15 |
| RA Capital Management, L.P. | — | — | 2 | $19.9M | 2020-12-03 |
| Julian Baker | — | — | 1 | $15.0M | 2017-10-05 |
| David M. Mott | 10% Owner | — | 1 | $9.3M | 2017-10-10 |
| Forest Baskett | 10% Owner | — | 1 | $9.3M | 2017-10-10 |
| Peter J. Barris | 10% | — | 1 | $9.3M | 2017-10-10 |
| Patrick J. Kerins | 10% Owner | — | 1 | $9.3M | 2017-10-10 |
| Scott D. Sandell | 10% Owner | — | 1 | $9.3M | 2017-10-10 |
| Peter J. Barris | 10% Owner | — | 1 | $9.3M | 2017-10-10 |
| M. James Barrett | 10% Owner | — | 1 | $9.3M | 2017-10-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David P. Meeker | CEO & President | Sell | $5.1M | 2026-09-14 |
| Hunter C. Smith | CFO | Sell | $6.6M | 2026-08-31 |
| Jennifer Kayden Lee | VP | Sell | $8.9M | 2026-08-13 |
| Alastair Garfield | CSO | Sell | $913K | 2026-08-13 |
| Joseph Shulman | CTO | Sell | $608K | 2026-08-13 |
| Yann Mazabraud | VP | Sell | $6.6M | 2026-08-12 |
Companies that share insiders with RYTM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Lynn A. Tetrault | Director | Sell | $3.7M | 2026-06-22 |
| Christopher Paul German | CAO & Controller | Sell | $428K | 2026-05-15 |
| Christopher Paul German | Controller | Sell | $503K | 2026-03-04 |
| Hunter C. Smith | CFO | Sell | $806K | 2026-02-17 |
| Hunter C. Smith | CFO | Sell | $709K | 2026-02-10 |
| Hunter C. Smith | CFO | Sell | $703K | 2026-02-04 |
| Pamela J. Cramer | CHRO | Sell | $372K | 2025-12-11 |
| Pamela J. Cramer | CHRO | Sell | $352K | 2025-11-20 |
| Pamela J. Cramer | CHRO | Sell | $4.2M | 2025-11-07 |